The acquisition was Valeant's first big transaction after losing a hostile bid in 2014 for Botox maker Allergan, which went instead to Actavis ...
Valeant
Today, Mizuho reiterated its Buy rating on Allergan PLC. (NYSE:AGN) with a price target of $273.00. There are 6 hold ratings, 19 buy ratings on the stock. The current consensus rating on Allergan PLC. (NYSE:AGN) is …
Allergan PLC
Brent Saunders readily acknowledged that 2016 was a difficult year for Allergan and for him personally. He admitted that "we did not do well …
Allergan
A number of other research analysts also recently issued reports on the stock. Sanford C. Bernstein set a $275.00 target price on shares of Allergan PLC. and gave the company a “buy” rating in a research report on …
Investment
While conservative estimates indicate a market size of slightly over $500 million for Esmya, AGN expects to generate anywhere between $500 million and $1 billion. After selling its generic business to Teva through a …
uterine fibroids
With Allergan plc Ordinary Shares (NYSE:AGN) on track for its fifth consecutive win -- and a nearly 6% weekly gain -- the drugmaker's call options are flying off the shelves at double the usual intraday rate. At last check, …
Allergan
The weekly performance is 0.83% for Allergan plc, while the monthly performance measure stands at 1.49%. The Company has 52-week high of $125.72 and 52-week low of $91.4. Royal Bank Of Canada cut their price target …
Presbyterian Ladies' College, Perth
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Allergan PLC (AGN), where a total volume of 19,856 contracts has been traded thus far today, a …
underlying shares
Out of 18 analysts covering Allergan Inc. (NYSE:AGN), 14 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means …
Allergan
The stock of Allergan plc Ordinary Shares (NYSE:AGN) is a huge mover today! About 878,557 shares traded hands. Allergan plc Ordinary Shares (NYSE:AGN) has declined 11.29% since June 3, 2016 and is …